Product Description
AB-Pacli 100MG provided by our company, is designed and manufactured by our workers for treating breast cancer, pancreatic cancer and non-small cell lung cancer. This medicine acts as an anti-cancer medication. This medicine works by interfering with the microtubule structures which help the cancer cells to divide and multiply. AB-Pacli 100MG should be taken as per the doctors prescription. This also helps in slowing the growth of cancer cells and eventually kills them. This is very effective and economical to use.
Advanced Chemotherapy Solution for Multiple CancersAB-PACLI 100MG provides a protein-bound (albumin-bound) formulation of Paclitaxel, enhancing its delivery and effectiveness in chemotherapy regimens for selected cancers. Indicated for breast, ovarian, and NSCLC, as well as AIDS-related Kaposis sarcoma, it adheres to rigorous WHO-GMP manufacturing standards. The lyophilized powder requires reconstitution for administration via intravenous infusion, supporting flexible integration into oncology protocols.
Safety and Handling with Cytotoxic PreparationsThis product demands cautious handling as a cytotoxic agent, ensuring both healthcare professionals and patients are protected. AB-PACLI 100MG comes in a secure glass vial with a flip-off seal, and all waste must be managed as hazardous material. The formulation is odorless, colorless to pale yellow, and is stored effectively below 25C, shielded from light for optimal stability throughout its 24-month shelf life.
FAQs of AB-PACLI 100MG:
Q: How should AB-PACLI 100MG be prepared and administered?
A: AB-PACLI 100MG must be reconstituted with a recommended sterile solution before administration. Once reconstituted, it is given via intravenous infusion, compatible with standard IV solutions. Preparation and administration should be performed by trained healthcare professionals using appropriate cytotoxic precautions.
Q: What cancers can AB-PACLI 100MG be used to treat?
A: This medication is indicated for the treatment of breast cancer, ovarian cancer, non-small cell lung cancer (NSCLC), and AIDS-related Kaposis sarcoma, as prescribed by an oncologist.
Q: When should AB-PACLI 100MG be stored and how should it be handled?
A: The vial should be stored below 25C and protected from light. Handling requires the use of gloves and cytotoxic precautions due to its hazardous nature. Waste products from preparation and administration must be managed as cytotoxic waste.
Q: Where can I obtain AB-PACLI 100MG?
A: AB-PACLI 100MG is available through registered distributors, exporters, suppliers, traders, and wholesalers in India. A valid prescription from a qualified healthcare provider is required to obtain and administer this medication.
Q: What are the benefits of the protein-bound (albumin-bound) formulation in AB-PACLI 100MG?
A: The protein-bound formulation enhances the delivery of Paclitaxel to cancer cells, potentially improving efficacy and reducing some side effects compared to traditional solvent-based formulations. This can provide better tolerance for some patients.
Q: What safety precautions are necessary when handling this medication?
A: Because AB-PACLI 100MG is cytotoxic, protective equipment such as gloves and masks should be worn during preparation and administration. All waste and materials that come in contact with the drug must be handled as hazardous waste.
Q: Is a prescription required for AB-PACLI 100MG and who should supervise its use?
A: Yes, AB-PACLI 100MG is a prescription-only medication and must be administered under the supervision of a qualified healthcare professional, typically within a clinical setting due to its complex preparation and potential side effects.